Literature DB >> 24155384

Activation of influenza A viruses by host proteases from swine airway epithelium.

Catharina Peitsch1, Hans-Dieter Klenk, Wolfgang Garten, Eva Böttcher-Friebertshäuser.   

Abstract

Pigs are important natural hosts of influenza A viruses, and due to their susceptibility to swine, avian, and human viruses, they may serve as intermediate hosts supporting adaptation and genetic reassortment. Cleavage of the influenza virus surface glycoprotein hemagglutinin (HA) by host cell proteases is essential for viral infectivity. Most influenza viruses, including human and swine viruses, are activated at a monobasic HA cleavage site, and we previously identified TMPRSS2 and HAT to be relevant proteases present in human airways. We investigated the proteolytic activation of influenza viruses in primary porcine tracheal and bronchial epithelial cells (PTEC and PBEC, respectively). Human H1N1 and H3N2 viruses replicated efficiently in PTECs and PBECs, and viruses containing cleaved HA were released from infected cells. Moreover, the cells supported the proteolytic activation of HA at the stage of entry. We found that swine proteases homologous to TMPRSS2 and HAT, designated swTMPRSS2 and swAT, respectively, were expressed in several parts of the porcine respiratory tract. Both proteases cloned from primary PBECs were shown to activate HA with a monobasic cleavage site upon coexpression and support multicycle replication of influenza viruses. swAT was predominantly localized at the plasma membrane, where it was present as an active protease that mediated activation of incoming virus. In contrast, swTMPRSS2 accumulated in the trans-Golgi network, suggesting that it cleaves HA in this compartment. In conclusion, our data show that HA activation in porcine airways may occur by similar proteases and at similar stages of the viral life cycle as in human airways.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24155384      PMCID: PMC3911738          DOI: 10.1128/JVI.01635-13

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  52 in total

1.  Activation of influenza A viruses by trypsin treatment.

Authors:  H D Klenk; R Rott; M Orlich; J Blödorn
Journal:  Virology       Date:  1975-12       Impact factor: 3.616

Review 2.  Evolution and ecology of influenza A viruses.

Authors:  R G Webster; W J Bean; O T Gorman; T M Chambers; Y Kawaoka
Journal:  Microbiol Rev       Date:  1992-03

3.  Persistent respiratory virus infection in tracheal organ cultures.

Authors:  S E Reed
Journal:  Br J Exp Pathol       Date:  1969-08

4.  Infection by influenza A viruses of tracheal organ cultures derived from homologous and heterologous hosts.

Authors:  R C Schmidt; H F Maassab; F M Davenport
Journal:  J Infect Dis       Date:  1974-01       Impact factor: 5.226

5.  Identification of novel influenza A virus proteins translated from PA mRNA.

Authors:  Yukiko Muramoto; Takeshi Noda; Eiryo Kawakami; Ramesh Akkina; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2012-12-12       Impact factor: 5.103

6.  Genetic relatedness of hemagglutinins of the H1 subtype of influenza A viruses isolated from swine and birds.

Authors:  C Scholtissek; H Bürger; P A Bachmann; C Hannoun
Journal:  Virology       Date:  1983-09       Impact factor: 3.616

7.  Proprotein-processing endoproteases PC6 and furin both activate hemagglutinin of virulent avian influenza viruses.

Authors:  T Horimoto; K Nakayama; S P Smeekens; Y Kawaoka
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

Review 8.  Source for influenza pandemics.

Authors:  C Scholtissek
Journal:  Eur J Epidemiol       Date:  1994-08       Impact factor: 8.082

Review 9.  Type II transmembrane serine proteases in development and disease.

Authors:  Roman Szabo; Thomas H Bugge
Journal:  Int J Biochem Cell Biol       Date:  2007-12-04       Impact factor: 5.085

10.  Influenza and SARS-coronavirus activating proteases TMPRSS2 and HAT are expressed at multiple sites in human respiratory and gastrointestinal tracts.

Authors:  Stephanie Bertram; Adeline Heurich; Hayley Lavender; Stefanie Gierer; Simon Danisch; Paula Perin; Jared M Lucas; Peter S Nelson; Stefan Pöhlmann; Elizabeth J Soilleux
Journal:  PLoS One       Date:  2012-04-30       Impact factor: 3.240

View more
  13 in total

1.  Identification of a broad-spectrum antiviral small molecule against severe acute respiratory syndrome coronavirus and Ebola, Hendra, and Nipah viruses by using a novel high-throughput screening assay.

Authors:  Hatem A Elshabrawy; Jilao Fan; Christine S Haddad; Kiira Ratia; Christopher C Broder; Michael Caffrey; Bellur S Prabhakar
Journal:  J Virol       Date:  2014-02-05       Impact factor: 5.103

2.  Influenza A virus mimetic nanoparticles trigger selective cell uptake.

Authors:  Sara Maslanka Figueroa; Anika Veser; Kathrin Abstiens; Daniel Fleischmann; Sebastian Beck; Achim Goepferich
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-29       Impact factor: 11.205

3.  TMPRSS2 Is the Major Activating Protease of Influenza A Virus in Primary Human Airway Cells and Influenza B Virus in Human Type II Pneumocytes.

Authors:  Hannah Limburg; Anne Harbig; Dorothea Bestle; David A Stein; Hong M Moulton; Julia Jaeger; Harshavardhan Janga; Kornelia Hardes; Janine Koepke; Leon Schulte; Andreas Rembert Koczulla; Bernd Schmeck; Hans-Dieter Klenk; Eva Böttcher-Friebertshäuser
Journal:  J Virol       Date:  2019-10-15       Impact factor: 5.103

Review 4.  An overview of influenza A virus genes, protein functions, and replication cycle highlighting important updates.

Authors:  Ravendra P Chauhan; Michelle L Gordon
Journal:  Virus Genes       Date:  2022-04-26       Impact factor: 2.332

5.  TMPRSS2 Activates Hemagglutinin-Esterase Glycoprotein of Influenza C Virus.

Authors:  Ko Sato; Hideki Hayashi; Yoshitaka Shimotai; Mutsuo Yamaya; Seiji Hongo; Kazuyoshi Kawakami; Yoko Matsuzaki; Hidekazu Nishimura
Journal:  J Virol       Date:  2021-08-18       Impact factor: 5.103

6.  Equine and Canine Influenza H3N8 Viruses Show Minimal Biological Differences Despite Phylogenetic Divergence.

Authors:  Kurtis H Feng; Gaelle Gonzalez; Lingquan Deng; Hai Yu; Victor L Tse; Lu Huang; Kai Huang; Brian R Wasik; Bin Zhou; David E Wentworth; Edward C Holmes; Xi Chen; Ajit Varki; Pablo R Murcia; Colin R Parrish
Journal:  J Virol       Date:  2015-04-22       Impact factor: 5.103

7.  The differentiated airway epithelium infected by influenza viruses maintains the barrier function despite a dramatic loss of ciliated cells.

Authors:  Nai-Huei Wu; Wei Yang; Andreas Beineke; Ronald Dijkman; Mikhail Matrosovich; Wolfgang Baumgärtner; Volker Thiel; Peter Valentin-Weigand; Fandan Meng; Georg Herrler
Journal:  Sci Rep       Date:  2016-12-22       Impact factor: 4.379

8.  Different residues in the SARS-CoV spike protein determine cleavage and activation by the host cell protease TMPRSS2.

Authors:  Lennart Michel Reinke; Martin Spiegel; Teresa Plegge; Anika Hartleib; Inga Nehlmeier; Stefanie Gierer; Markus Hoffmann; Heike Hofmann-Winkler; Michael Winkler; Stefan Pöhlmann
Journal:  PLoS One       Date:  2017-06-21       Impact factor: 3.240

9.  Hemagglutinins of Avian Influenza Viruses Are Proteolytically Activated by TMPRSS2 in Human and Murine Airway Cells.

Authors:  Dorothea Bestle; Hannah Limburg; Diana Kruhl; Anne Harbig; David A Stein; Hong Moulton; Mikhail Matrosovich; Elsayed M Abdelwhab; Jürgen Stech; Eva Böttcher-Friebertshäuser
Journal:  J Virol       Date:  2021-07-28       Impact factor: 5.103

10.  Avian Influenza A Virus Infects Swine Airway Epithelial Cells without Prior Adaptation.

Authors:  Dai-Lun Shin; Wei Yang; Ju-Yi Peng; Bevan Sawatsky; Veronika von Messling; Georg Herrler; Nai-Huei Wu
Journal:  Viruses       Date:  2020-05-28       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.